152 related articles for article (PubMed ID: 10785838)
1. Neurophysiology of sensorimotor integration in Parkinson's disease.
Rossini PM; Filippi MM; Vernieri F
Clin Neurosci; 1998; 5(2):121-30. PubMed ID: 10785838
[TBL] [Abstract][Full Text] [Related]
2. Pre- and postcentral cortical somatosensory evoked potentials in hemiparkinsonism.
Huttunen J; Teräväinen H
Mov Disord; 1993 Oct; 8(4):430-6. PubMed ID: 8232352
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
4. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
[TBL] [Abstract][Full Text] [Related]
5. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
Devos D; Defebvre L
Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
[TBL] [Abstract][Full Text] [Related]
6. Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
Rascol OJ; Sabatini U; Chollet F; Montastruc JL; Marc-Vergnes JP; Rascol A
Adv Neurol; 1993; 60():419-21. PubMed ID: 8420165
[No Abstract] [Full Text] [Related]
7. Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease.
Manfredi L; Garavaglia P; Beretta S; Pellegrini G
Neurophysiol Clin; 1998 Feb; 28(1):31-8. PubMed ID: 9562997
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of somatosensory evoked potentials in spasmodic torticollis.
Mazzini L; Zaccala M; Balzarini C
Mov Disord; 1994 Jul; 9(4):426-30. PubMed ID: 7969209
[TBL] [Abstract][Full Text] [Related]
9. Levodopa affects functional brain networks in Parkinsonian resting tremor.
Pollok B; Makhloufi H; Butz M; Gross J; Timmermann L; Wojtecki L; Schnitzler A
Mov Disord; 2009 Jan; 24(1):91-8. PubMed ID: 18823037
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease.
Mir P; Matsunaga K; Gilio F; Quinn NP; Siebner HR; Rothwell JC
Neurology; 2005 Jun; 64(11):1906-12. PubMed ID: 15955942
[TBL] [Abstract][Full Text] [Related]
11. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
Mongeon D; Blanchet P; Messier J
Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
[TBL] [Abstract][Full Text] [Related]
12. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD.
Ulivelli M; Rossi S; Pasqualetti P; Rossini PM; Ghiglieri O; Passero S; Battistini N
Neurology; 1999 Oct; 53(7):1451-7. PubMed ID: 10534250
[TBL] [Abstract][Full Text] [Related]
13. Deficient "sensory" beta synchronization in Parkinson's disease.
Degardin A; Houdayer E; Bourriez JL; Destée A; Defebvre L; Derambure P; Devos D
Clin Neurophysiol; 2009 Mar; 120(3):636-42. PubMed ID: 19208497
[TBL] [Abstract][Full Text] [Related]
14. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
Traversa R; Pierantozzi M; Semprini R; Loberti M; Cicardi MC; Bassi A; Stanzione P
J Neural Transm Suppl; 1995; 45():177-85. PubMed ID: 8748624
[TBL] [Abstract][Full Text] [Related]
15. Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson's disease.
MacKinnon CD; Webb RM; Silberstein P; Tisch S; Asselman P; Limousin P; Rothwell JC
Eur J Neurosci; 2005 Mar; 21(5):1394-402. PubMed ID: 15813949
[TBL] [Abstract][Full Text] [Related]
16. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
[TBL] [Abstract][Full Text] [Related]
17. Short and long latency afferent inhibition in Parkinson's disease.
Sailer A; Molnar GF; Paradiso G; Gunraj CA; Lang AE; Chen R
Brain; 2003 Aug; 126(Pt 8):1883-94. PubMed ID: 12805105
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease and lower limb somatosensory evoked potentials: apomorphine-induced relief of the akinetic-rigid syndrome and vertex P37-N50 potentials.
Tinazzi M; Fiaschi A; Idone D; Tezzon F; Zanette G
J Neurol Sci; 1999 Apr; 164(2):163-71. PubMed ID: 10402029
[TBL] [Abstract][Full Text] [Related]
19. Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations.
Caviness JN; Adler CH; Beach TG; Wetjen KL; Caselli RJ
Mov Disord; 2002 Jul; 17(4):657-62. PubMed ID: 12210853
[TBL] [Abstract][Full Text] [Related]
20. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
